Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

213
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
213
Tonsillitis II: Management01:26

Tonsillitis II: Management

423
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
423
Management of Insomnia01:19

Management of Insomnia

609
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
609
Managing Impressions01:19

Managing Impressions

168
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
168
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

516
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
516
Angina IV: Management01:26

Angina IV: Management

275
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
275

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point of view: Task-specific movement disorders-time for a reappraisal?

Parkinsonism & related disorders·2026
Same author

RRP12 Variants Are Associated With Autosomal Recessive Brain Calcifications.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Myoclonus, dystonia and parkinsonism due to a de novo novel variant in the NUS1 gene: Furthering the epilepsy-dyskinesia spectrum - Expert commentary.

Parkinsonism & related disorders·2025
Same author

Deep Phenotyping of Musicians' Upper Limb Dystonia.

Tremor and other hyperkinetic movements (New York, N.Y.)·2025
Same author

The Spectrum of Neurologic Phenotypes Associated With NUS1 Pathogenic Variants: A Comprehensive Case Series.

Annals of neurology·2025
Same author

Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS]).

Movement disorders : official journal of the Movement Disorder Society·2025

Related Experiment Video

Updated: Jan 27, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K

An Update on Myoclonus Management.

Christine M Stahl1, Steven J Frucht1

  • 1a NYU Langone Health , The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, A Parkinson's Foundation Center of Excellence , New York , NY , USA.

Expert Review of Neurotherapeutics
|March 16, 2019
PubMed
Summary
This summary is machine-generated.

Myoclonus, a movement disorder causing sudden jerks, is difficult to treat and lacks extensive clinical trials. Reviving study groups is crucial for collaborative research into effective myoclonus treatments.

Keywords:
deep brain stimulationmyoclonusperampaneltreatmentzonisamide

More Related Videos

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

872
Measuring and Mapping Patterns of Soil Erosion and Deposition Related to Soil Carbonate Concentrations Under Agricultural Management
08:09

Measuring and Mapping Patterns of Soil Erosion and Deposition Related to Soil Carbonate Concentrations Under Agricultural Management

Published on: September 12, 2017

12.3K

Related Experiment Videos

Last Updated: Jan 27, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

872
Measuring and Mapping Patterns of Soil Erosion and Deposition Related to Soil Carbonate Concentrations Under Agricultural Management
08:09

Measuring and Mapping Patterns of Soil Erosion and Deposition Related to Soil Carbonate Concentrations Under Agricultural Management

Published on: September 12, 2017

12.3K

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Myoclonus is a hyperkinetic movement disorder defined by sudden, involuntary jerks.
  • Numerous causes exist, making etiology and characteristics critical for diagnosis and treatment.
  • Effective management often requires multiple medications, highlighting treatment challenges.

Purpose of the Study:

  • To review the fundamentals and classification of myoclonus.
  • To discuss current management strategies for myoclonus.
  • To highlight recent advancements in pharmacologic and surgical treatments for myoclonus.

Main Methods:

  • Literature review of myoclonus basics, classification, and management.
  • Focus on recent updates in pharmacologic and surgical interventions.
  • Analysis of expert opinions and case series guiding treatment.

Main Results:

  • Myoclonus management remains challenging due to a lack of high-quality clinical trials.
  • Etiological heterogeneity complicates the design of clinical trials.
  • Expert experience and case series currently guide treatment decisions.

Conclusions:

  • There is a significant need for more rigorous clinical trials to guide myoclonus treatment.
  • Collaborative, multicenter clinical trials are essential for advancing treatment paradigms.
  • Reviving international myoclonus study groups can facilitate such collaborative research.